Oslo Cancer Cluster member Sarsia Seed and Tromsø-based Norinnova have been given the managment of two new national seed capital funds on MNOK 300 in total by the Norwegian government. The money will be matched by privat capital.
The venture session at the DNB Healthcare Conference features three Oslo Cancer Cluster member companies: Lytix Biopharma, Vaccibody and Regencis. They will all present in session five: Therapeutics, that starts at 15:00.
BILAG DAGENS NÆRINGSLIV
Meltwater Newsfeed :
- Forbedret diagnostikk for prostatakreft på vei November 26, 2015
- Targovax ASA: Interim report third quarter 2015 November 26, 2015
- Sier ja til to nye medisiner mot føflekkreft November 25, 2015
- Pasienter med føflekkreft får endelig de nye, revolusjonerende medisinene November 25, 2015